Nazartinib
- Generic Name
- Nazartinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H31ClN6O2
- CAS Number
- 1508250-71-2
- Unique Ingredient Identifier
- KE7K32EME8
- Background
Nazartinib is under investigation in clinical trial NCT03529084 (Phase III Study of Nazartinib (EGF816) Versus Erlotinib/gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating Mutations).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath